Barclays PLC Arcturus Therapeutics Holdings Inc. Call Options Transaction History
Barclays PLC
- $377 Billion
- Q3 2024
Call Options
2 transactions
Others Institutions Holding ARCT
# of Institutions
179Shares Held
25.6MCall Options Held
195KPut Options Held
133K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$79.7 Million0.25% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$45 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.2.32MShares$39.3 Million0.62% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.28MShares$38.6 Million0.04% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.1MShares$35.7 Million0.46% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $451M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...